Nano-navigated macrophages: Piercing liver inflammation, fibrosis, and cancer

Alazne Moreno-Lanceta, Elazer R. Edelman, João Conde, Pedro Melgar-Lesmes

Research output: Contribution to journalComment/debatepeer-review

Abstract

The incidence of chronic liver disease is increasing worldwide. Inflammation is a driving force in this disease; however, there is a need to further define the centrality of macrophages. With advances in nanotechnology, the therapeutic landscape of modulating macrophages against liver inflammation, fibrosis, and cancer can be considered using nanotherapeutics.

Original languageEnglish
Pages (from-to)3234-3237
Number of pages4
JournalMatter
Volume7
Issue number10
DOIs
Publication statusPublished - 2 Oct 2024

Cite this